Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | CCR5 | P51681 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7804488 | 0.90 | AVPR1A (0.54) | AVPR1AALDH1A1POLBHTTMEN1 | |
| SCHEMBL7811765 | 0.83 | AVPR1A (0.54) | AVPR1AALDH1A1POLBHTTMEN1 | |
| SCHEMBL7810120 | 0.83 | POLB (0.48) | ALDH1A1POLBHTTMEN1KMT2A | |
| SCHEMBL7804716 | 0.80 | AVPR1A (0.57) | AVPR1AALDH1A1POLBHTTMEN1 | |
| SCHEMBL7804359 | 0.79 | ALDH1A1 (0.50) | AVPR1AALDH1A1POLBHTTMEN1 | |
| SCHEMBL7811441 | 0.78 | MME (0.46) | ALDH1A1POLBMEN1KMT2A | |
| SCHEMBL7804540 | 0.78 | AVPR1A (0.55) | AVPR1AALDH1A1POLBHTTMEN1 | |
| SCHEMBL7817608 | 0.77 | ALDH1A1 (0.50) | AVPR1AALDH1A1POLBHTTMEN1 | |
| SCHEMBL7804350 | 0.75 | AVPR1A (0.44) | AVPR1AALDH1A1POLBHTTMEN1 | |
| SCHEMBL7804342 | 0.74 | ALDH1A1 (0.49) | AVPR1AALDH1A1POLBHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0607536-B1 | Arylamide derivatives | SS PHARMACEUTICAL CO (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-5532371-A | SIDE EFFECT REDUCTION | SS PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5411972-A | Arylamide derivatives for treating hyperlipemia | SS PHARMACEUTICAL CO., LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| EP-0607536-A1 | Arylamide derivatives | SS PHARMACEUTICAL CO., LTD. (JP) | 1994-07-27 | — | — | EP | disclosed |